Re: Aborted Fetuses in Vaccines(Sources)
Cell Lines Originating from Aborted Babies
There are two particular fetal cell lines that have been heavily used in vaccine development. They are named according to the laboratory facilities where they were developed. One cell line is known as WI-38, developed at the Wistar Institute in Philadelphia, PA. The other is MRC-5, developed for the Medical Research Council in England. WI-38 was developed by Dr. Leonard Hayflick in 1962, by taking lung cells from an aborted female baby at approximately the end of the third month of pregnancy. Dr. Hayflick's article published in the scientific journal, Experimental Cell Research states that three cell lines, WI-26, WI-38, WI-44 were all developed from aborted babies. "All embryos were obtained from surgical abortions and were of approximately three months' gestation [1]." In another journal article (American Journal of Diseases of Childhood) from an international conference on Rubella, Dr. Stanley Plotkin who developed a Rubella vaccine using WI-38, addressed a question as to the origin of WI-38. Dr. Plotkin stated, "This fetus was chosen by Dr. Sven Gard, specifically for this purpose. Both parents are known, and unfortunately for the story, they are married to each other, still alive and well, and living in Stockholm, presumably. The abortion was done because they felt they had too many children. There were no familial diseases in the history of either parent, and no history of cancer specifically in the families [2]."
The origin of the MCR-5 cell line, created in 1966, is documented in an article in the journal Nature by three British researchers working at the National Institute for Medical Research. J.P. Jacobs, et. al. write, "We have developed another strain of cells, also derived from foetal lung tissue, taken from a 14-week male foetus removed for psychiatric reasons from a 27 year old woman with a genetically normal family history and no sign of neoplastic disease both at abortion and for at least three years afterward [3]." Noting that their research parallels that of Dr. Hayflick's development of the WI-38 cell line, the researchers conclude, "Our studies indicate that by presently accepted criteria, MRC-5 cells - in common with WI-38 cells of similar origin - have normal characteristics and so could be used for the same purposes as WI-38 cells [4]."
http://www.rtl.org/prolife_issues/LifeNotes/VaccinesAbortion_FetalTissue.html
"Rabies vaccine, human diploid cell (HDCV) Imovax"
From
http://www.medaccess.com/cdcimun/Rubella/Rub1_02.htm
The live rubella virus vaccine* currently distributed in the United States is prepared human diploid cell culture. In January 1979, this vaccine (RA 27/3) replaced the HPV-77:DE-5 vaccine grown in duck embryo cell culture because it induced higher seroresponse, greater resistance to reinfection, and lower reaction rate. Although both subcutaneous and intranasal administration of the vaccine have been studied, the vaccine is licensed only for subcutaneous administration. The vaccine is produced in monovalent form (rubella only) and in combinations: measles-rubella (MR), rubella-mumps, and measles-mumps-rubella (MMR) vaccines. *Official name: rubella virus vaccine, live.
(3) MERUVAX II (Rubella Virus Vaccine Live, MSD), the Wistar
RA 27/3 strain of live attenuated rubella virus grown in human diploid cell (W1-38) culture."
Attenuation Of
RA 27/3 Rubella Virus in WI-38 Human Diploid Cells; Amer J Dis Child vol 118 Aug 1969
Explant cultures were made of the dissected organs of a particular fetus aborted because of rubella, the 27th in our series of fetuses aborted during the 1964 epidemic. The third explant, which happened to be from kidney, was selected arbitrarily for further study.
Studies of Immunization With Living Rubella Virus ; Arch J Dis Child vol 110 Oct 1965 This fetus was from a 25 year old mother exposed to rubella 8 days after last menstrual period. 16 days later she developed rubella. The fetus was surgically aborted 17 days after maternal illness and dissected immediately. Explants from several organs were cultured and successful cell growth was achieved from lung, skin, and kidney. It was then grown on WI-38. This new vaccine was tested on orphans in Philadelphia.
Poliovirus Vaccine Inactivated PolioVax Source: 1996 PHYSICIAN'S DESK REFERENCE
The viruses are grown in human diploid (MRC-5) cell cultures, concentrated purified and inactivated with formaldehyde. Poliovax contains formaldehyde, 2-phenoxyethanol, traces of bovine serum and may contain trace amounts of streptomycin and/or polymyxin B and neomycin, the possibility of allergic reactions in individuals sensitive to these substances should be borne in mind when considering the use of this vaccine.
Bivax (Rubella and Mumps Virus Vaccine Live, MSD, U.S.P.)
Source: 1996 PHYSICIAN'S DESK REFERENCE
Bivax is a sterile lyophilized preparation of the Wistar
RA 27/3 strain of live attenuated rubella virus grown in human diploid cell (WI-38) culture; and the Jeryl Lynn (B level) strain of mumps virus grown in cell cultures of chick embryo.